Medline (MDLN) Financials: Revenue & Earnings
MDLN$32.49+0.11 +0.34%
$28.50B
Market Cap
39.17
P/E
21.83
Forward P/E
44
Score
Medline (MDLN) Financials: Revenue & Earnings
MDLN price $32.49 +0.11 +0.34%
- Ticker
- MDLN
- Price
- $32.49
- Change
- +0.11 +0.34%
- Market cap ?
- $28.50B
- P/E ?
- 39.17
- Forward P/E ?
- 21.83
- Dividend yield ?
- 0.00%
- Beta ?
- -0.41
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Stocklytics score
- 44
- Value
- 53
- Quality
- 40
- Growth
- 39
Stocklytics score rationale: value 53, quality 40, growth 39.
Financials
| 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|
| 21448000000 | 23231000000 | 25507000000 | 28432000000 |
Medline Inc. is a global manufacturer of medical and surgical products, catering to a broad spectrum of healthcare providers. Their clientele includes hospitals, surgical centers, physician practices, post-acute care facilities, and nursing homes, both domestically and worldwide. The company's operations are divided into two primary divisions: the Medline Brand and Supply Chain Solutions. The Medline Brand division…
Fair value
MDLN fair value $40.91. Price $32.49. Price is 21% below fair value.
Above fair value, but less expensive than usual. A smaller premium than on 78% of days in the past 5 years.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 2.03B. Growth 12.71%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 10.00%. Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 877.35M. Net debt 10.62B. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-04 | — | 0.34 | — | 7.72B |
| 2026-08-05 | 0.50 | 0.35 | 7.68B | 7.52B |
| 2026-05-06 | 0.33 | 0.30 | 7.35B | 7.16B |
| 2026-02-25 | 0.22 | 0.24 | 7.79B | 7.51B |
| 2025-11-04 | 0.31 | — | 7.12B | — |
Dividends
Yield 0.00%. Payout ratio 13.89%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 14% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-08 | GIC Private Ltd | Sell | 7.82M | $35.15 | 274.77M |
| 2026-10-06 | GIC Private Ltd | Sell | 7.18M | $35.05 | 251.76M |
| 2026-10-06 | GIC Private Ltd | Sell | 2.09M | $35.05 | 73.22M |
| 2026-10-05 | GIC Private Ltd | Sell | 1.69M | $35.78 | 60.42M |
| 2026-10-02 | GIC Private Ltd | Sell | 7.15M | $34.33 | 245.35M |
| 2026-10-02 | GIC Private Ltd | Sell | 2.57M | $35.35 | 90.88M |
| 2026-08-19 | Boyle James M | Buy | 764.25K | $16.49 | 12.60M |
| 2026-08-19 | Miller Stephen L | Buy | 87.67K | $19.01 | 1.67M |
| 2026-08-14 | GIC Private Ltd | Sell | 100.00K | $35.80 | 3.58M |
| 2026-08-13 | GIC Private Ltd | Sell | 1.50M | $35.80 | 53.70M |
| 2026-08-07 | GIC Private Ltd | Sell | 590.28K | $35.58 | 21.00M |
| 2026-08-06 | Mozart Holdco, Inc. | Sell | 500.00K | — | — |
| 2026-08-06 | Mozart Holdco, Inc. | Sell | 500.00K | — | — |
| 2026-08-06 | Mozart Holdco, Inc. | Buy | 500.00K | — | — |
| 2026-08-06 | GIC Private Ltd | Sell | 271.99K | $35.33 | 9.61M |
| 2026-08-05 | GIC Private Ltd | Sell | 1.71M | $35.46 | 60.67M |
| 2026-08-05 | GIC Private Ltd | Sell | 265.71K | $36.48 | 9.69M |
| 2026-05-28 | BCP 8 Holdings Mozart Manager L.L.C. | Sell | 19.71M | $36.54 | 720.24M |
| 2026-05-28 | BCP 8 Holdings Mozart Manager L.L.C. | Sell | 2.26M | $36.54 | 82.46M |
| 2026-05-28 | BCP 8 Holdings Mozart Manager L.L.C. | Sell | 438.21K | — | — |
| 2026-05-28 | BCP 8 Holdings Mozart Manager L.L.C. | Sell | 9.86M | $36.54 | 360.21M |
| 2026-05-28 | BCP 8 Holdings Mozart Manager L.L.C. | Sell | 1.49M | $36.54 | 54.44M |
| 2026-05-21 | BCP 8 Holdings Mozart Manager L.L.C. | Sell | 9.86M | — | — |
| 2026-05-21 | BCP 8 Holdings Mozart Manager L.L.C. | Sell | 9.86M | — | — |
| 2026-05-21 | BCP 8 Holdings Mozart Manager L.L.C. | Buy | 9.86M | — | — |
| 2026-05-21 | BCP 8 Holdings Mozart Manager L.L.C. | Sell | 1.49M | — | — |
| 2026-05-21 | BCP 8 Holdings Mozart Manager L.L.C. | Sell | 1.49M | — | — |
| 2026-05-21 | BCP 8 Holdings Mozart Manager L.L.C. | Buy | 1.49M | — | — |
| 2026-03-10 | Carlyle Group Inc. | Sell | 26.11M | $41.00 | 1.07B |
| 2026-03-10 | Carlyle Group Inc. | Sell | 2.11M | — | — |
| 2026-03-10 | BCP 8 Holdings Mozart Manager L.L.C. | Sell | 16.48M | $40.51 | 667.53M |
| 2026-03-10 | BCP 8 Holdings Mozart Manager L.L.C. | Sell | 1.89M | $40.51 | 76.42M |
| 2026-03-10 | BCP 8 Holdings Mozart Manager L.L.C. | Sell | 366.34K | — | — |
| 2026-03-10 | BCP 8 Holdings Mozart Manager L.L.C. | Sell | 8.24M | $40.51 | 333.86M |
| 2026-03-10 | BCP 8 Holdings Mozart Manager L.L.C. | Sell | 1.25M | $40.51 | 50.45M |
| 2026-03-05 | Carlyle Group Inc. | Buy | 1.21M | — | — |
| 2026-03-05 | Carlyle Group Inc. | Sell | 1.21M | — | — |
| 2026-03-05 | Carlyle Group Inc. | Sell | 1.21M | — | — |
| 2026-03-05 | BCP 8 Holdings Mozart Manager L.L.C. | Sell | 1.08M | — | — |
| 2026-03-05 | BCP 8 Holdings Mozart Manager L.L.C. | Sell | 1.08M | — | — |
| 2026-03-05 | BCP 8 Holdings Mozart Manager L.L.C. | Sell | 162.46K | — | — |
| 2026-03-05 | BCP 8 Holdings Mozart Manager L.L.C. | Sell | 162.46K | — | — |
| 2026-03-05 | BCP 8 Holdings Mozart Manager L.L.C. | Buy | 1.08M | — | — |
| 2026-03-05 | BCP 8 Holdings Mozart Manager L.L.C. | Buy | 162.46K | — | — |
| 2026-03-04 | Carlyle Group Inc. | Buy | 8.09M | — | — |
| 2026-03-04 | Carlyle Group Inc. | Sell | 8.09M | — | — |
| 2026-03-04 | Carlyle Group Inc. | Sell | 8.09M | — | — |
| 2026-03-04 | BCP 8 Holdings Mozart Manager L.L.C. | Sell | 7.17M | — | — |
| 2026-03-04 | BCP 8 Holdings Mozart Manager L.L.C. | Sell | 7.17M | — | — |
| 2026-03-04 | BCP 8 Holdings Mozart Manager L.L.C. | Sell | 1.08M | — | — |
| 2026-03-04 | BCP 8 Holdings Mozart Manager L.L.C. | Sell | 1.08M | — | — |
| 2026-03-04 | BCP 8 Holdings Mozart Manager L.L.C. | Buy | 7.17M | — | — |
| 2026-03-04 | BCP 8 Holdings Mozart Manager L.L.C. | Buy | 1.08M | — | — |
| 2026-01-16 | Carlyle Group Inc. | Sell | 111.99M | — | — |
| 2026-01-16 | Carlyle Group Inc. | Sell | 55.56M | — | — |
| 2026-01-16 | Carlyle Group Inc. | Sell | 55.56M | — | — |
| 2025-12-18 | Carlyle Group Inc. | Buy | 6.82M | — | — |
| 2025-12-18 | Carlyle Group Inc. | Sell | 19.14M | $29.00 | 554.95M |
| 2025-12-18 | Carlyle Group Inc. | Sell | 1.55M | — | — |
| 2025-12-18 | Carlyle Group Inc. | Sell | 6.82M | — | — |
| 2025-12-18 | Carlyle Group Inc. | Sell | 6.82M | — | — |
| 2025-12-18 | Mozart Aggregator II LP | Sell | 13.46M | $28.37 | 381.91M |
| 2025-12-18 | Mozart Aggregator II LP | Sell | 268.54K | — | — |
| 2025-12-18 | Mozart Aggregator II LP | Sell | 6.95M | — | — |
| 2025-12-18 | Mozart Aggregator II LP | Sell | 6.95M | — | — |
| 2025-12-17 | Carlyle Group Inc. | Other | 0 | — | — |
| 2025-12-17 | Carlyle Group Inc. | Other | 0 | — | — |
| 2025-12-17 | Carlyle Group Inc. | Other | 77.74M | — | — |
| 2025-12-17 | Mozart Aggregator II LP | Other | 0 | — | — |
| 2025-12-17 | Mozart Aggregator II LP | Other | 0 | — | — |
| 2025-12-17 | Mozart Aggregator II LP | Other | 0 | — | — |
| 2025-12-17 | Mozart Aggregator II LP | Other | 79.33M | — | — |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 425, holders +95 vs prior quarter. Ownership 104.31%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| CARLYLE GROUP INC. | 187.08M | 0 | 0.00% | 7.38B |
| BLACKSTONE INC. | 101.79M | -22.41M | -18.04% | 4.01B |
| H&F CORPORATE INVESTORS X, LTD. | 70.87M | -15.60M | -18.04% | 2.80B |
| FMR LLC | 46.96M | 10.41M | +28.47% | 1.85B |
| CAPITAL RESEARCH GLOBAL INVESTORS | 39.96M | 16.80M | +72.54% | 1.58B |
| INVESCO LTD. | 38.35M | 17.38M | +82.92% | 1.51B |
| BLACKROCK, INC. | 26.39M | 9.47M | +55.96% | 1.04B |
| MORGAN STANLEY | 21.61M | 5.90M | +37.59% | 852.13M |
| LONE PINE CAPITAL LLC | 20.97M | 9.18M | +77.86% | 826.99M |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 19.89M | 8.32M | +71.91% | 787.12M |
| VANGUARD CAPITAL MANAGEMENT LLC | 17.82M | 3.09M | +20.95% | 702.67M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 16.78M | 2.63M | +18.59% | 661.84M |
| EGERTON CAPITAL (UK) LLP | 16.47M | 12.11M | +277.27% | 649.61M |
| JUPITER TOPCO LLC | 15.86M | 15.86M | New | 625.44M |
| DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN | 11.96M | 7.57M | +172.69% | 471.58M |
| BAILLIE GIFFORD & CO | 11.34M | 1.37M | +13.71% | 447.37M |
| NORGES BANK | 8.48M | 8.48M | New | 334.27M |
| STATE STREET CORP | 8.45M | 3.62M | +75.16% | 333.15M |
| GEODE CAPITAL MANAGEMENT, LLC | 7.95M | 1.69M | +27.01% | 312.74M |
| SURGOCAP PARTNERS LP | 7.49M | 1.41M | +23.25% | 295.31M |
| WCM INVESTMENT MANAGEMENT, LLC | 7.40M | 178.92K | +2.48% | 293.02M |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 7.36M | 2.36M | +47.11% | 290.10M |
| BANQUE PICTET & CIE SA | 7.31M | 5.89M | +414.59% | 288.39M |
| ALYESKA INVESTMENT GROUP, L.P. | 6.81M | 3.87M | +131.81% | 268.55M |
| UBS GROUP AG | 6.43M | 3.24M | +101.49% | 253.64M |
Earnings and financials
Medline Inc. (MDLN) trades at $32.49, with a market cap of $28.50B and a trailing P/E of 39.17. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|
| 21448000000 | 23231000000 | 25507000000 | 28432000000 |
Insights · Dividends · Forecast · Financials · Learn